Journal of Applied Physiology AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 94: 991-996, 2003. First published October 4, 2002; doi:10.1152/japplphysiol.00746.2001
8750-7587/03 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
94/3/991    most recent
00746.2001v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garske, L. A.
Right arrow Articles by Morrison, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garske, L. A.
Right arrow Articles by Morrison, S. C.
Vol. 94, Issue 3, 991-996, March 2003

Acetazolamide reduces exercise capacity and increases leg fatigue under hypoxic conditions

Luke A. Garske, Michael G. Brown, and Stephen C. Morrison

Department of Thoracic Medicine, Royal Brisbane Hospital, Brisbane, Queensland 4029, Australia

Acetazolamide (Acz) is used at altitude to prevent acute mountain sickness, but its effect on exercise capacity under hypoxic conditions is uncertain. Nine healthy men completed this double-blind, randomized, crossover study. All subjects underwent incremental exercise to exhaustion with an inspired O2 fraction of 0.13, hypoxic ventilatory responses, and hypercapnic ventilatory responses after Acz (500 mg twice daily for 5 doses) and placebo. Maximum power of 203 ± 38 (SD) W on Acz was less than the placebo value of 225 ± 40 W (P < 0.01). At peak exercise, arterialized capillary pH was lower and PO2 higher on Acz (P < 0.01). Ventilation was 118.6 ± 20.0 l/min at the maximal power on Acz and 102.4 ± 20.7 l/min at the same power on placebo (P < 0.02), and Borg score for leg fatigue was increased on Acz (P < 0.02), with no difference in Borg score for dyspnea. Hypercapnic ventilatory response on Acz was greater (P < 0.02), whereas hypoxic ventilatory response was unchanged. During hypoxic exercise, Acz reduced exercise capacity associated with increased perception of leg fatigue. Despite increased ventilation, dyspnea was not increased.

control of breathing; hypoxia; acidosis


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
V. Faoro, S. Huez, S. Giltaire, A. Pavelescu, A. van Osta, J.-J. Moraine, H. Guenard, J.-B. Martinot, and R. Naeije
Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes
J Appl Physiol, October 1, 2007; 103(4): 1161 - 1165.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. M. Jonk, I. P. van den Berg, I. M. Olfert, D. W. Wray, T. Arai, S. R. Hopkins, and P. D. Wagner
Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise
J. Physiol., March 15, 2007; 579(3): 909 - 921.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. Zoll, E. Ponsot, S. Dufour, S. Doutreleau, R. Ventura-Clapier, M. Vogt, H. Hoppeler, R. Richard, and M. Fluck
Exercise training in normobaric hypoxia in endurance runners. III. Muscular adjustments of selected gene transcripts
J Appl Physiol, April 1, 2006; 100(4): 1258 - 1266.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online